Tag: Fosun Pharma
Iksuda Therapeutics advances IKS014 in Phase 1 trial following positive initial results
Iksuda Therapeutics, a clinical-stage biotechnology firm from the UK specializing in innovative antibody drug conjugates (ADCs) for tumor specificity, reported successful completion of the first ... Read More
Fosun Pharma signs licensing deal with Henlius Biotech for serplulimab
Fosun Pharma has signed an exclusive US licensing agreement with Shanghai Henlius Biotech for commercializing the latter’s serplulimab, an anti-PD-1 monoclonal antibody (mAb). The financial ... Read More
COVID-19 RT-PCR detection kit : Fosun Pharma secures FDA EUA status
Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug ... Read More